Skip to content

Clinical trials

Phase 2/3 Stroke trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 2/3 Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20041
20053
20061
20073
20085
20096
20104
20112
20121
20133
20143
20153
20166
20172
20185
20193
20203
20214
20221
20235
20244
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Unknown status20
Terminated12
Recruiting7
Not yet recruiting4
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Capital Medical University4
Federal University of Paraíba3
Assistance Publique - Hôpitaux de Paris2
Beijing Tiantan Hospital2
Seoul National University Bundang Hospital2
Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC2
University of Alberta2
University of Calgary2
University of California, Los Angeles2
Acticor Biotech1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke79
Ischemic Stroke23
Cerebral Infarction6
Cerebrovascular Disorders5
Ischemic Attack, Transient5
Cardiovascular Diseases4
Myocardial Infarction4
Aphasia3
Brain Diseases3
Brain Injuries, Traumatic3

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.